全文获取类型
收费全文 | 15489篇 |
免费 | 941篇 |
国内免费 | 79篇 |
专业分类
耳鼻咽喉 | 108篇 |
儿科学 | 385篇 |
妇产科学 | 203篇 |
基础医学 | 2491篇 |
口腔科学 | 291篇 |
临床医学 | 1279篇 |
内科学 | 3259篇 |
皮肤病学 | 465篇 |
神经病学 | 1654篇 |
特种医学 | 615篇 |
外科学 | 2257篇 |
综合类 | 54篇 |
一般理论 | 7篇 |
预防医学 | 786篇 |
眼科学 | 488篇 |
药学 | 1097篇 |
中国医学 | 16篇 |
肿瘤学 | 1054篇 |
出版年
2023年 | 74篇 |
2022年 | 113篇 |
2021年 | 258篇 |
2020年 | 172篇 |
2019年 | 215篇 |
2018年 | 271篇 |
2017年 | 249篇 |
2016年 | 330篇 |
2015年 | 341篇 |
2014年 | 490篇 |
2013年 | 577篇 |
2012年 | 930篇 |
2011年 | 955篇 |
2010年 | 650篇 |
2009年 | 604篇 |
2008年 | 1052篇 |
2007年 | 1093篇 |
2006年 | 1087篇 |
2005年 | 1114篇 |
2004年 | 998篇 |
2003年 | 936篇 |
2002年 | 914篇 |
2001年 | 273篇 |
2000年 | 189篇 |
1999年 | 223篇 |
1998年 | 220篇 |
1997年 | 153篇 |
1996年 | 137篇 |
1995年 | 128篇 |
1994年 | 91篇 |
1993年 | 110篇 |
1992年 | 85篇 |
1991年 | 85篇 |
1990年 | 83篇 |
1989年 | 80篇 |
1988年 | 100篇 |
1987年 | 74篇 |
1986年 | 69篇 |
1985年 | 62篇 |
1984年 | 55篇 |
1983年 | 58篇 |
1982年 | 68篇 |
1981年 | 39篇 |
1980年 | 45篇 |
1979年 | 40篇 |
1978年 | 43篇 |
1977年 | 42篇 |
1976年 | 41篇 |
1974年 | 40篇 |
1973年 | 36篇 |
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
991.
Effect of the stage of lactation in
humans on carotenoid levels in milk,blood plasma and plasma
lipoprotein fractions 总被引:1,自引:0,他引:1
Schweigert FJ Bathe K Chen F Büscher U Dudenhausen JW 《European journal of nutrition》2004,43(1):39-44
Summary. In mammals the composition of milk changes during early
lactation, with a rapid decline of fat-soluble vitamins and a
continuous increase in total lipids. The mechanisms underlying
this phenomenon are not well understood, but might involve
selective mechanisms related to mammary uptake or secretion into
the milk. Since carotenoids are specifically distributed among
the lipoprotein fractions in plasma, the simultaneous
determination of carotenoids in plasma, lipoprotein fractions
and milk might offer an opportunity to gain insight into this
phenomenon. In 21 healthy mothers carotenoids in plasma and
lipoprotein fractions were investigated at day 2 and 19 and milk
on day 4 and 19 after delivery. Plasma levels of -tocopherol
and cholesterol as well as lutein, zeaxanthin and cryptoxanthin
were significantly lower later in lactation (day 19) than
shortly after birth (P < 0.01). The stage of lactation had no
effect on the distribution of carotenoids and -tocopherol among
the plasma lipoprotein fractions. In milk, triacylglycerol
increased (P < 0.01). In contrast, levels of carotenoids,
-tocopherol and vitamin A were highest in colostrum and
declined (P < 0.01). Because the magnitude of decrease was
not the same in all carotenoids, the carotenoid pattern changed
substantially. In colostrum the carotenoid pattern resembled
those of plasma and the low-density lipoprotein fraction. In
mature milk it was similar to the pattern found in the high
density lipoprotein fraction. Based on these observations a
selective mechanism might be responsible for the transfer of
these components in milk involving different lipoprotein
fractions at specific times of lactation. 相似文献
992.
993.
Interlaboratory evaluation of rat hepatic gene expression changes induced by methapyrilene 下载免费PDF全文
Waring JF Ulrich RG Flint N Morfitt D Kalkuhl A Staedtler F Lawton M Beekman JM Suter L 《Environmental health perspectives》2004,112(4):439-448
Several studies using microarrays have shown that changes in gene expression provide information about the mechanism of toxicity induced by xenobiotic agents. Nevertheless, the issue of whether gene expression profiles are reproducible across different laboratories remains to be determined. To address this question, several members of the Hepatotoxicity Working Group of the International Life Sciences Institute Health and Environmental Sciences Institute evaluated the liver gene expression profiles of rats treated with methapyrilene (MP). Animals were treated at one facility, and RNA was distributed to five different sites for gene expression analysis. A preliminary evaluation of the number of modulated genes uncovered striking differences between the five different sites. However, additional data analysis demonstrated that these differences had an effect on the absolute gene expression results but not on the outcome of the study. For all users, unsupervised algorithms showed that gene expression allows the distinction of the high dose of MP from controls and low dose. In addition, the use of a supervised analysis method (support vector machines) made it possible to correctly classify samples. In conclusion, the results show that, despite some variability, robust gene expression changes were consistent between sites. In addition, key expression changes related to the mechanism of MP-induced hepatotoxicity were identified. These results provide critical information regarding the consistency of microarray results across different laboratories and shed light on the strengths and limitations of expression profiling in drug safety analysis. 相似文献
994.
995.
Pedrosa R Gomes P Zeng C Hopfer U Jose PA Soares-da-Silva P 《British journal of pharmacology》2004,142(8):1343-1353
This study evaluated the response of the Na(+)/H(+) exchanger (NHE) to dopamine D(1)- and D(2)-like receptor stimulation in immortalized renal proximal tubular epithelial cells and freshly isolated renal proximal tubules from the spontaneously hypertensive rat (SHR) and their normotensive controls (Wistar Kyoto rats; WKY). Stimulation of D(1)-like receptors with SKF 38393 attenuated NHE activity in WKY cells (IC(50)=151 nM), but not in SHR cells. Stimulation of D(2)-like receptors with quinerolane (IC(50)=120 nM) attenuated NHE activity in SHR cells, but not in WKY cells. Forskolin was equipotent in SHR and WKY cells in inhibiting NHE activity. The effect of SKF 38393 was abolished by overnight treatment of WKY cells with cholera toxin (CTX, 500 ng ml(-1)), but not with pertussis toxin (PTX, 100 ng ml(-1)). The effect of quinerolane (1 microm) was abolished by overnight treatment of SHR cells with PTX, but not with CTX. The D(3) receptor agonist 7-OH-DPAT (IC(50)=0.8 microM) attenuated NHE activity in SHR cells only. This effect was abolished by S-sulpiride and by overnight treatment with PTX. The D(4) receptor agonist RBI 257 did not affect NHE activity. The 7-OH-DPAT inhibited NHE activity in freshly isolated renal proximal tubules from 4- and 12-week-old SHR and 12-week-old WKY, but not in freshly isolated renal proximal tubules from 4-week-old WKY. It is concluded that D(3) receptors coupled to a G(i/o) protein play a role in the handling of tubular Na(+), namely through inhibition of the NHE activity, this being of particular relevance in the SHR, which fail to respond to D(1)-like dopamine receptor stimulation. 相似文献
996.
997.
Pharmacokinetics of intravenous, single-dose tiotropium in subjects with different degrees of renal impairment 总被引:1,自引:0,他引:1
Türck D Weber W Sigmund R Budde K Neumayer HH Fritsche L Rominger KL Feifel U Slowinski T 《Journal of clinical pharmacology》2004,44(2):163-172
Tiotropium, a new potent anticholinergic bronchodilator, is excreted mainly by the kidney. To investigate the pharmacokinetics of tiotropium in renal impairment, the authors evaluated the pharmacokinetics and safety after administration of a single dose of intravenous tiotropium 4.8 microg, given as an infusion over 15 minutes in subjects with normal renal function and a wide range of renal impairment based on measured creatinine clearance (normal: > 80 mL/min, n = 6; mild impairment: > 50-80 mL/min, n = 5; moderate impairment: 30-50 mL/min, n = 7; severe impairment: < 30 mL/min, n =6). As expected for a drug excreted predominantly in unchanged form by the kidneys, tiotropium plasma concentrations increased as renal impairment worsened, with mean values of 55.5 (16.2 percent geometric coefficient of variation [%gCV]), 77.1 (20.1 %gCV), 101 (29.8 %gCV), and 108 (27.3 %gCV) pgh/mL for AUC(0-4h) in the normal renal function and the mild, moderate, and severe renal impairment groups, respectively. The percentage of tiotropium dose excreted unchanged in the urine decreased from 60.1% of dose (17.7 %gCV) to 59.3% (14.4 %gCV), 39.9% (34.5 %gCV), and 37.4% (10.2 %gCV) in the normal renal function and the mild, moderate, and severe renal impairment groups, respectively. Plasma protein binding of tiotropium did not significantly change in the renal-impaired subjects. Two subjects with normal renal function experienced headache 10 hours after the infusion, which was mild and transient. No adverse events occurred in subjects with renal impairment. There were no clinically relevant changes in blood pressure, pulse rate, 12-lead ECG, physical examination, hematology, or clinical chemistry, compared with baseline values, in any subject after intravenous administration of tiotropium. Tiotropium should only be used in patients with moderate to severe renal insufficiency if the potential benefit outweighs the potential risks. 相似文献
998.
Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers 总被引:3,自引:0,他引:3
Van Ryn J Kink-Eiband M Kuritsch I Feifel U Hanft G Wallenstein G Trummlitz G Pairet M 《Journal of clinical pharmacology》2004,44(7):777-784
This study determined if meloxicam, a selective cyclooxygenase (COX)-2 inhibitor, interferes with the antiplatelet effect of aspirin using platelet aggregation and thromboxane (Tx) B(2) endpoints in healthy volunteers. Eight male and 8 female volunteers participated in this open-label, randomized, two-treatment, two-way crossover trial. Treatment 1 was meloxicam (15 mg qd) over 4 days, and then aspirin (100 mg qd) was ingested 2 hours after meloxicam for an additional 7 days. Blood samples were taken 2, 6, and 24 hours after the last dose. Treatment 2 consisted of only aspirin (100 mg) over 2 days. Samples were taken at the same time points. Each subject received both treatments with a 2-week washout between the treatment periods. Treatments were safe and well tolerated. The initial 4-day treatment with meloxicam had no effect on platelet aggregation but reduced serum TxB(2) by 64% +/- 19%. Addition of aspirin (100 mg qd) for 7 days resulted in complete inhibition of aggregation and TxB(2) for 24 hours. Two-day treatment with only 100 mg aspirin also resulted in complete inhibition of platelet aggregation and TxB(2). These results indicate that meloxicam does not affect the ability of aspirin to inhibit COX-1 in platelets, thereby allowing aspirin to effectively prevent platelet aggregation and reduce TxB(2) levels, and that meloxicam is selective for COX-2. 相似文献
999.
Corticosteroids mediate seizure activity in different epilepsy models or epilepsies. However, for childhood absence epilepsy, a nonconvulsive type of epilepsy, direct evidence for corticosteroid seizure modulation is lacking. Thus, in the present study, we analysed the acute systemic effects of different doses of the corticosteroid corticosterone on seizure activity in a well-validated animal model of childhood absence epilepsy, the WAG/Rij rat. We found a time- and dose-dependent increase in the number of spike-wave discharges (SWD) in the EEG, with 500 microg/kg of corticosterone causing a 327% increase in discharges compared to baseline 15-30 min after administration. No treatment effects were found on mean duration of SWD and behavior. Our data indicate that corticosterone in a physiologically relevant dose can aggravate absence seizures in a rapid but transient way. Regarding the time course of the effect, we suggest that corticosterone is acting nongenomically, possibly via a temporary increase of excitatory amino acids. 相似文献
1000.
Schaefer CA Kuhlmann CR Gast C Weiterer S Li F Most AK Neumann T Backenköhler U Tillmanns H Waldecker B Wiecha J Erdogan A 《Vascular pharmacology》2004,41(2):67-73
The proliferation of endothelial cells is induced by oxidized low-density lipoprotein (oxLDL) and its major component, lysophosphatidylcholine (LPC). The aim of this study was to investigate the effect of statins on the proliferation of endothelial cells derived from human umbilical cord veins (HUVEC). Cerivastatin, simvastatin and fluvastatin caused a dose-dependent inhibition of endothelial cell growth (n=12; P<.01) when using cell counts and [3H]-thymidine incorporation, respectively. The strongest inhibition of HUVEC proliferation was achieved at statin concentrations of 0.1 micromol/l (cerivastatin), 2.5 micromol/l (simvastatin) and 1 micromol/l (fluvastatin). Cell counts were significantly reduced from 22937+/-280.6 (control) to 7791+/-133.6 (cerivastatin), 7292+/-146.6 (simvastatin) and 6792+/-135.5 (fluvastatin) (n=12; P<.01). Interestingly, cell proliferation induced by oxLDL (10 microg/ml) and LPC (20 micromol/l) could be effectively prevented using statins at concentrations between 0.01 and 0.1 micromol/l (cerivastatin), 1 and 2.5 micromol/l (simvastatin) and 0.25 and 1 micromol/l (fluvastatin). This effect of the statins was abolished by preincubation with mevalonate (500 micromol/l). Our results demonstrate an interesting direct effect of statins on the proliferation of human endothelial cells induced by oxLDL and LPC, which may be beneficial to prevent vascular effects of these atherogenic lipids. 相似文献